HPV vaccines Flashcards

1
Q

PV grows in tissue cultures like

A

HeLa or Vero cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

.

A

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are most commonly HPV vaccinse composed of

A

Virus-like particles (VLPs) of L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cervavrix (UK)
What cell is used
Adjuvant
VLP formation
HPV types its effective against

A

Insect cells with recombinant baculovirus
ASO4, alum, TL4 ligand, MPL
Truncated L1, forms VLPs
16/18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gardasil
What cell is used
Adjuvant
VLP formation
HPV types its effective against

A

Yeast
Alum based
VLPs are disassembled and reassembled
16/18/6/11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many doses does HPV vaccination require

A

Three IM doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In Cervavix why is L1 truncated

A

Helps with synthesis and impurities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In Gardasil were was L1 cloned from and why didn’t it work so what was used instead to get it from

A

From carcinoma, was mutated.
Repeated with L1 from lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What HPV vaccine did the UK switch to

A

Gardasil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How many doses are now considered sufficient

A

Two of Gardasil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do Pap smearts detect

A

Abnormal cells (koilocyes) indicative of HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In situ hybridisation is useful in what

A

Diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Are CINs cancer?

A

No but can develop into it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does in situ hybridisation localise

A

Specific DNA/RNA sequences, PCR can be used to detect HPV16 in CINIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of CIN 2/3 often involves what surgery

A

Conisation: Excise wedge from cervix including transformation zone, high risk of coming back

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Imiquimod is an analogue of what

A

Imidazoquinolone is an analogue of guanosisine

17
Q

What does Imiquimod activate

A

TLR7/TLR8 mediated inflammatory responses in DCs

18
Q

What cancers is imiquimod used for

A

Basal cell carcinoma and squamous cell carnicomas

19
Q

Herd immunity requires how much uptake

20
Q

Oral HPV is more common in what sex; what cancer does it cause

A

Men, causing head and neck cancers

21
Q

What are co-infections common with what type of HPV

A

HPV45, they are common and commener with ager

22
Q

New approaches to HPV vaccines

A
  1. Include L1 from other HPVs? i.e. 31, 33, 35, 39, 45, 52 and 58 –
  2. Inclusion of L2 – would this increase efficacy or cross-type specificity?
  3. Epitope swapping
  4. An RNA vaccine
23
Q

Gardasil 9 contains what GPV types

A

HPV types 16, 18, 31, 33, 35, 39, 45, 52 and 58 which are most commonly known to cause cervical cancer.

24
Q

How are RNAs vaccines possible

A

Alternatively could make a cheaper more accessible one, making it in E. coli, a subunit-vaccine, delivery alongside current vaccines or novel delivery strat.
An E.coli derived vaccine could pose a problem due to LPS, animal vaccines are an option, cell free expression is still expensive

25
Q

Therapeutic vaccies could include for those already infected

A

Viral DNA
Viral proteins/peptide
Peptide presentation systems

26
Q

Describe a generic VLP vaccine scaffold (tip think of HepB)

A

Use a VLP that is easy to make to present foreign epitopes like hep B core particles decorated with HPV sequences. This is a generic VLP vaccine scaffold.

27
Q

What are aptamers

A

Oligonucleotides that fold into complex structures and bind to their targets in a conformation-dependent manner

28
Q

RNA aptamers are produced how

A

Produced via SELEC (in vitro selection), sequenntial rounds of +ve and -ve selelction with target of interest. Stabilised against nuclease attack with fluoropyrimidines

29
Q

What aptamer is approved for clinical use , site of injection

A

Macugen, injected into eye

30
Q

What type of wave could potentially be used therapetutically